Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score
- PMID: 29687050
- PMCID: PMC5910169
- DOI: 10.1016/j.ejro.2018.03.002
Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score
Abstract
Introduction: The purpose was to investigate the usefulness of ADCratio on Diffusion MRI to discriminate between benign and malignant lesions of Prostate.
Methods: Images of patients who underwent in-gantry MRI guided prostate lesion biopsy were retrospectively analyzed. Prostate Cancers with 20% or more Gleason score (GS) pattern 3 + 3 = 6 in each core or any volume of higher Gleason score pattern were included. ADCratio was calculated by two reviewers for each lesion. The ADCratio was calculated for each lesion by dividing the lowest ADC value in a lesion and highest ADC value in normal prostate in peripheral zone (PZ). ADCratio values were compared with the biopsy result. Data was analysed using independent samples T-test, Spearman correlation, intra-class correlation coefficient (ICC) and Receiver operating characteristic (ROC) curve.
Results: 45 lesions in 33 patients were analyzed. 12 lesions were in transitional zone (TZ) and 33 in perpheral zone PZ. All lesions demonstrated an ADCratio of 0.45 or lower. GS demonstrated a negative correlation with both the ADC value and ADCratio. However, ADCratio (p < 0.001) demonstrated a stronger correlation compared to ADC value alone (p = 0.014). There was no significant statistical difference between GS 3 + 4 and GS 4 + 3 mean ADCtumour value (p = 0.167). However when using ADCratio, there was a significant difference (p = 0.032). ROC curve analysis demonstrated an area under the curve of 0.83 using ADCratio and 0.76 when using ADCtumour value when discriminating Gleason 6 from Gleason ≥7 tumours. Inter-observer reliability in the calculation of ADC ratios was excellent, with ICC of 0.964.
Conclusion: ADCratio is a reliable and reproducible tool in quantification of diffusion restriction for clinically significant prostate cancer foci.
Keywords: Diffusion magnetic resonance imaging; Magnetic resonance imaging; Prostate; Prostatic cancer; Prostatic neoplasms.
Figures



Similar articles
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.AJR Am J Roentgenol. 2019 Sep;213(3):W134-W142. doi: 10.2214/AJR.19.21365. Epub 2019 Jun 19. AJR Am J Roentgenol. 2019. PMID: 31216201
-
Diffusion-weighted imaging of the prostate: should we use quantitative metrics to better characterize focal lesions originating in the peripheral zone?Eur Radiol. 2018 May;28(5):2236-2245. doi: 10.1007/s00330-017-5107-2. Epub 2017 Nov 22. Eur Radiol. 2018. PMID: 29168004
-
Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.J Magn Reson Imaging. 2015 Aug;42(2):446-53. doi: 10.1002/jmri.24801. Epub 2014 Nov 19. J Magn Reson Imaging. 2015. PMID: 25408104
-
Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis.Eur Radiol. 2025 Jan;35(1):404-416. doi: 10.1007/s00330-024-10890-6. Epub 2024 Jul 12. Eur Radiol. 2025. PMID: 38995382
Cited by
-
Quantitative magnetic resonance imaging in prostate cancer: A review of current technology.World J Radiol. 2024 Oct 28;16(10):497-511. doi: 10.4329/wjr.v16.i10.497. World J Radiol. 2024. PMID: 39494137 Free PMC article. Review.
-
DWI-related texture analysis for prostate cancer: differences in correlation with histological aggressiveness and data repeatability between peripheral and transition zones.Eur Radiol Exp. 2022 Jan 12;6(1):1. doi: 10.1186/s41747-021-00252-y. Eur Radiol Exp. 2022. PMID: 35018507 Free PMC article.
-
Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.Br J Radiol. 2022 Mar 1;95(1131):20210842. doi: 10.1259/bjr.20210842. Epub 2021 Sep 19. Br J Radiol. 2022. PMID: 34538077 Free PMC article.
-
Non-timely clinically applicable ADC ratio in prostate mpMRI: a comparison with fusion biopsy results.Abdom Radiol (NY). 2022 Nov;47(11):3855-3867. doi: 10.1007/s00261-022-03627-w. Epub 2022 Aug 9. Abdom Radiol (NY). 2022. PMID: 35943517 Free PMC article.
-
Incidence and Predicting Factors of Histopathological Features at Robot-Assisted Radical Prostatectomy in the mpMRI Era: Results of a Single Tertiary Referral Center.Medicina (Kaunas). 2023 Mar 21;59(3):625. doi: 10.3390/medicina59030625. Medicina (Kaunas). 2023. PMID: 36984626 Free PMC article.
References
-
- Kim C.K., Park B.K., Lee H.M., Kwon G.Y. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest. Radiol. 2007;42:842–847. - PubMed
-
- Purysko A.S., Rosenkrantz A.B., Barentsz J.O., Weinreb J.C., Macura K.J. PI-RADS version 2: a pictorial update. Radiographics. 2016;36:1354–1372. - PubMed
-
- Wu X., Reinikainen P., Vanhanen A. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer. Diagn. Interv. Imaging. 2017;98:63–71. - PubMed
-
- Hambrock T., Somford D.M., Huisman H.J. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259:453–461. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources